Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.